Kunal Shastri, MSc

Senior Director, Global Market Access & Pharmacoeconomics
Fresenius Kabi, SwissBioSim GmbH, Switzerland

Poster(s):

• (26) The economic benefit of biosimilars in North America: a targeted literature review
  Wednesday, October 29, 2025

• (100) The Economic Impact of Ustekinumab in the Treatment of Psoriasis: A Targeted Literature Review
  Wednesday, October 29, 2025

• (287) Analyzing the economic impact of denosumab in the treatment of osteoporosis
  Wednesday, October 29, 2025